Latest Period
Q1 2026
Security Snapshot
Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY) Institutional Ownership
CUSIP: 90466Y202
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
51
Shares (Excl. Options)
9,906,082
Price
$6.58
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- UNCY on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 9,906,082
- Total 13F value
- $65,206,284
- Portfolio coverage rank
- 0%
- Share change
- +1,609,886
- Value change
- +$10,637,370
- Number of holders
- 51
- Shares outstanding
- 28,293,758
- SEC-reported price per share
- $7.95
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- UNCY - Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 90466Y202.
- 51 institutions reported positions in Q1 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 34 to 51 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $47,021,122 to $65,206,284.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 51 institutions filings for Q1 2026.
Security key
90466Y202
Latest holder period
Q1 2026
13F holders
51
13D/G owners
7
CIK / CUSIP context first
Open Q1 2026 holders
UNCY full holder history
Unicycive Therapeutics, Inc. SEC filings
Unicycive Therapeutics, Inc. company facts
Unicycive Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 90466Y202:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
UNCY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 10% | $26,579,323 | 6,096,175 | Vivo Opportunity Fund Holdings, L.P. | 30 Sep 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $18,066,979 | +$2,681,929 | 2,801,082 | +17% | RA Capital Management, L.P. | 31 Mar 2026 |
| Nantahala Capital Management, LLC | 10% | $13,389,705 | 2,281,040 | Nantahala Capital Management, LLC | 31 Dec 2025 | |||
| BIOTECHNOLOGY VALUE FUND L P | 10% | $7,439,864 | 1,417,117 | BVF PARTNERS L P/IL | 30 Jun 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 5.5% | $6,555,209 | 1,172,667 | Integrated Core Strategies (US) LLC | 16 Jan 2026 | |||
| Octagon Capital Advisors LP | 4.7% | -17% | $5,870,000 | 1,000,000 | 0% | Octagon Capital Advisors LP | 31 Dec 2025 | |
| GREAT POINT PARTNERS LLC | 4.5% | -29% | $3,472,993 | 796,558 | 0% | Great Point Partners, LLC | 30 Sep 2025 |
As of 31 Mar 2026, 51 institutional investors reported holding 9,906,082 shares of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY). This represents 35% of the company’s total 28,293,758 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
34%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 6.3% | 1,789,916 | 0% | 0.98% | $11,777,647 |
| MILLENNIUM MANAGEMENT LLC | 4.9% | 1,399,348 | +38% | 0.01% | $9,207,710 |
| Octagon Capital Advisors LP | 3.5% | 1,000,000 | 0% | 0.73% | $6,580,000 |
| Nantahala Capital Management, LLC | 3.3% | 939,202 | 0% | 0.39% | $6,179,949 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.9% | 811,430 | 0% | 0% | $5,339,209 |
| GREAT POINT PARTNERS LLC | 2.8% | 796,558 | 0% | 1.3% | $5,241,352 |
| Logos Global Management LP | 1.7% | 473,563 | 0% | 0.16% | $3,116,045 |
| CITADEL ADVISORS LLC | 0.84% | 236,841 | -8.3% | 0% | $1,558,414 |
| Integral Health Asset Management, LLC | 0.8% | 225,000 | 0.08% | $1,480,500 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.72% | 203,744 | +19% | 0% | $1,341,677 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.7% | 199,219 | +699% | 0% | $1,310,861 |
| MORGAN STANLEY | 0.67% | 188,182 | +304% | 0% | $1,238,237 |
| MARSHALL WACE, LLP | 0.55% | 154,938 | 0% | $1,019,492 | |
| Dauntless Investment Group, LLC | 0.52% | 147,087 | +64% | 2.7% | $967,832 |
| DIMENSIONAL FUND ADVISORS LP | 0.51% | 143,052 | 0% | $940,173 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.42% | 119,531 | 0% | 0% | $786,514 |
| DIADEMA PARTNERS LP | 0.37% | 106,083 | 0.31% | $698,026 | |
| VANGUARD FIDUCIARY TRUST CO | 0.36% | 101,074 | 0% | 0% | $665,067 |
| Diametric Capital, LP | 0.28% | 80,362 | 0.14% | $528,781 | |
| STATE STREET CORP | 0.28% | 80,027 | +23% | 0% | $526,578 |
| CANTOR FITZGERALD, L. P. | 0.27% | 75,000 | -62% | 0.02% | $493,500 |
| JANE STREET GROUP, LLC | 0.26% | 72,243 | 0% | $475,359 | |
| ACUTA CAPITAL PARTNERS, LLC | 0.2% | 57,959 | -3.4% | 0.27% | $381,370 |
| Seven Fleet Capital Management LP | 0.2% | 55,700 | 0.12% | $366,506 | |
| BARCLAYS PLC | 0.18% | 50,000 | +62400% | 0% | $329,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4